momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (11630)	8/9/2018 10:33:45 AM
From: Biotech Jim	Read Replies (1) of 12215

I have a small position in PIRS, but am a cautious holder. I continue to worry about antibody formation for the anti-calins. I agree with your views on the two programs regarding the return of the SNY and the Roche rights. Roche in particular has a very high bar for progressing programs in the clinic.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next